Reminder for Inspire Medical Systems Investors of Class Action Lawsuit by Faruqi & Faruqi, LLP

Investors in Inspire Medical Systems have been reminded by Faruqi & Faruqi, LLP of the ongoing class action lawsuit, with a lead plaintiff deadline set for January 5, 2026. The lawsuit focuses on allegations that Inspire Medical Systems made false and misleading statements to the investing public. The allegations claim that Inspire Medical Systems failed to disclose key information regarding their business practices that led to inflated stock prices.

The class action lawsuit targets Inspire Medical Systems’ prior public statements concerning their business and prospects. The suit alleges that the company failed to disclose crucial information regarding the commercial success of its flagship product, the Inspire Upper Airway Stimulation system. Investors claim that the company’s positive statements were misleading and caused them financial harm when the truth emerged.

Inspire Medical Systems’ stock price suffered a significant decline following revelations about the true state of the company’s business and the performance of its products. Investors who purchased shares during the specified class period and suffered financial losses as a result of the alleged misrepresentations have until January 5, 2026, to join the lawsuit as a lead plaintiff.

Investors who wish to become part of the class action lawsuit must meet certain criteria and submit the necessary documentation before the deadline. By participating in the lawsuit as a lead plaintiff, investors can actively represent the class and potentially recover financial losses incurred as a result of the alleged securities fraud committed by Inspire Medical Systems.

Faruqi & Faruqi, LLP has a track record of representing investors in securities class action lawsuits and has been actively pursuing claims against companies engaged in fraudulent practices. The firm is dedicated to seeking justice for investors who have been misled by companies that fail to disclose material information affecting their stock prices.

Investors who believe they have a valid claim against Inspire Medical Systems are encouraged to contact Faruqi & Faruqi, LLP to learn more about their rights and options in this class action lawsuit. By taking action and participating in the lawsuit, investors can hold Inspire Medical Systems accountable for any alleged securities law violations and work towards recovering their financial losses.

In conclusion, investors in Inspire Medical Systems have until January 5, 2026, to join the class action lawsuit as a lead plaintiff and seek compensation for any losses incurred due to alleged false and misleading statements made by the company. Faruqi & Faruqi, LLP is actively working to hold Inspire Medical Systems accountable for any securities law violations and is available to assist investors in pursuing their claims.